Amy M. Wetherby, Ph.D., CCC-SLP, is a Distinguished Research Professor in the Department of Clinical Sciences and Director of the Autism Institute in the College of Medicine and the Laurel Schendel Professor of Communication Disorders at Florida State University. She has over 35 years of clinical experience and is a Fellow of the American Speech-Language-Hearing Association. Dr. Wetherby has published extensively and presents regularly at national conventions on early detection and early intervention for children with autism spectrum disorders (ASD). She served on the National Academy of Sciences Committee for Educational Interventions for Children with Autism and on the DSM-5 Neurodevelopmental Workgroup of the American Psychiatric Association. Dr. Wetherby was Co-Director of several randomized clinical trials to study the efficacy of intervention models for young children with ASD funded by NIMH, US DOE/IES, and HHS/HRSA. She is Director of the FIRST WORDS® Project that conducts longitudinal research on screening tools for autism and communication disorders and developmental trajectories in large population-based samples of children 9-24 months of age funded by the US DOE/OSEP, NIDCD, CDC, and NICHD. Dr. Wetherby is co-developer of Autism Navigator®, an innovative collection of web-based courses and tools designed to bridge the gap between science and community practice using extensive video footage to illustrate effective evidence-based practice. She is Co-Director of a multisite health services research study funded by NIMH using Autism Navigator to mobilize communities to improve family engagement in earlier screening and diagnosis of ASD and communication delays and entry into early intervention. The overarching goal of the collective efforts of Dr. Wetherby’s research is to build the capacity of healthcare systems to improve early detection and provide access to cost-efficient early intervention that is feasible for far-reaching community implementation.